Influence of PRKCH gene polymorphism on antihypertensive response to amlodipine and telmisartan

References

• Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet 2007;370:591–603.
   PubMed Web of Science ®Google Scholar
• Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004;44:398–404.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics––2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:480–486.
   Google Scholar
• Na JO, Seo HS, Choi CU, et al. Results of a 14-week, multicenter, prospective, randomized, open-label, noninferiority clinical trial comparing the antihypertensive effect and edema incidence of lacidipine and amlodipine in older Korean patients with mild-to-moderate hypertension. Curr Ther Res Clin Exp 2013;74:54–61.
   PubMedGoogle Scholar
• Messerli FH. Evolution of calcium antagonists: past, present, and future. Clin Cardiol 2003;26(2 Suppl 2):II12–6.
   PubMed Web of Science ®Google Scholar
• Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial. Lancet 2004;363:2022–31.
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895–906.
   PubMed Web of Science ®Google Scholar
• de Gasparo M, Catt KJ, Inagami T, et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415–72.
   PubMed Web of Science ®Google Scholar
• Nagel JM, Tietz AB, Göke B, Parhofer KG. The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects. Metabolism 2006;55:1149–54.
   PubMed Web of Science ®Google Scholar
• Yin SN, Liu M, Jing DQ, et al. Telmisartan increases lipoprotein lipase expression via peroxisome proliferator-activated receptor-alpha in HepG2 cells. Endocr Res 2014;39:66–72.
   PubMed Web of Science ®Google Scholar
• Giles TD, Bakris GL, Smith DH, et al. Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trial. Am J Hypertens 2003;16:460–466.
   PubMed Web of Science ®Google Scholar
• Spitaler M, Cantrell DA. Protein kinase C and beyond. Nat Immunol 2004;5:785–790.
   PubMed Web of Science ®Google Scholar
• Kubo M, Hata J, Ninomiya T, et al. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 2007;39:212–217.
   PubMed Web of Science ®Google Scholar
• Pham TN, Brown BL, Dobson PR, Richardson VJ. Protein kinase C-eta (PRKη) is required for the development of inducible nitric oxide synthase (iNOS) positive phenotype in human monocytic cells. Nitric Oxide 2003;9:123–134.
   PubMed Web of Science ®Google Scholar
• Lenfant C, Chobanian AV, Jones DW, Roccella EJ. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension 2003;41:1178–9.
   Google Scholar
• Rioux PP. Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications. Am J Health Syst Pharm 2000;57:887–898.
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484–96.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Ando F, Shimokata H. Association of the genetic variants of APOA5 and PRKCH with hypertension in community-dwelling Japanese individuals. Mol Med Rep 2008;1:407–414.
   PubMed Web of Science ®Google Scholar
• Cheng H, Wang F, Ding X, et al. Association of PRKCH gene with lacunar infarction in a local Chinese Han population. Neurosci Lett 2009;464:146–149.
   PubMed Web of Science ®Google Scholar
• Matsuo R, Ago T, Hata J, et al. Impact of the 1425G/A polymorphism of PRKCH on the recurrence of ischemic stroke: Fukuoka Stroke Registry. J Stroke Cerebrovasc Dis 2014;23:1356–1361.
   PubMed Web of Science ®Google Scholar
• Wu L, Shen Y, Liu X, et al. The 1425G/A SNP in PRKCH is associated with ischemic stroke and cerebral hemorrhage in a Chinese population. Stroke 2009;40:2973–2976.
   PubMed Web of Science ®Google Scholar
• Li J, Luo M, Xu X, Sheng W. Association between 1425G/A SNP in PRKCH and ischemic stroke among Chinese and Japanese populations: a meta-analysis including 3686 cases and 4589 controls. Neurosci Lett 2012;506:55–58.
   PubMed Web of Science ®Google Scholar
• Sun L, Zhang Z, Ma M, et al. A quantitative assessment of the association between 1425G/A polymorphism in PRKCH and risk of stroke. Neuromol Med 2014;16:814–820.
   PubMed Web of Science ®Google Scholar
• Wu L, Xi B, Hou D, et al. The SNP (rs2230500) in PRKCH decreases the risk of carotid intima-media thickness in a Chinese young adult population. PLoS One 2012;7:e40606.
   PubMed Web of Science ®Google Scholar
• Goto Y, Hishida A, Matsuo K, et al. PRKCH gene polymorphism is associated with the risk of severe gastric atrophy. Gastric Cancer 2010;13:90–94.
   PubMed Web of Science ®Google Scholar
• Takata Y, Hamada D, Miyatake K, et al. Genetic association between the PRKCH gene encoding protein kinase C eat isozyme and rheumatoid arthritis in the Japanese population. Arthritis Rheumatol 2007;56:30–42.
   PubMed Web of Science ®Google Scholar